Extracellular vesicles - New tool for joint repair and regeneration

Nature Reviews Rheumatology

Volumn 12, Issue 4, 2016, Pages 243-249

  Malda, Jos ^a   Boere, Janneke ^b   Van De Lest, Chris H A ^c   Van Weeren, P René ^b   Wauben, Marca H M ^c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; MICRORNA; BIOLOGICAL MARKER;

ARTICULAR CARTILAGE; CELL COMMUNICATION; CELL THERAPY; CHONDROCYTE IMPLANTATION; EXOSOME; EXTRACELLULAR MATRIX; HOMEOSTASIS; HUMAN; HYDROGEL; JOINT REGENERATION; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; THERAPY EFFECT; TISSUE REGENERATION; TISSUE REPAIR; ARTHRITIS; JOINT; JOINT DISEASES; MEMBRANE MICROPARTICLE; NOMENCLATURE; PATHOPHYSIOLOGY; PHYSIOLOGY; REGENERATION; TRANSPLANTATION;

ARTHRITIS; BIOMARKERS; CELL COMMUNICATION; CELL-DERIVED MICROPARTICLES; EXTRACELLULAR MATRIX; EXTRACELLULAR VESICLES; HOMEOSTASIS; HUMANS; JOINT DISEASES; JOINTS; MICRORNAS; REGENERATION; TERMINOLOGY AS TOPIC;

EID: 84953330502     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2015.170     Document Type: Review

References (82)

1. Witwer, K. W. et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J. Extracell. Vesicles http://dx.doi.org/10.3402/jev.v2i0.20360 (2013).
2. Berckmans, R. J. et al. Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism. Arthritis Rheum. 46, 2857-2866 (2002).
3. Thery, C., Zitvogel, L. & Amigorena, S. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2, 569-579 (2002).
4. Thery, C., Ostrowski, M. & Segura, E. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 9, 581-593 (2009).
5. Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654-659 (2007).
6. Yanez-Mo, M. et al. Biological properties of extracellular vesicles and their physiological functions. J. Extracell. Vesicles 4, 27066 (2015).
7. Zomer, A. et al. In vivo imaging reveals extracellular vesicle-mediated phenocopying of metastatic behavior. Cell 161, 1046-1057 (2015).
8. Ridder, K. et al. Extracellular vesicle-mediated transfer of genetic information between the hematopoietic system and the brain in response to inflammation. PLoS Biol. 12, e1001874 (2014).
9. Anderson, H. C. Vesicles associated with calcification in the matrix of epiphyseal cartilage. J. Cell Biol. 41, 59-72 (1969).
10. Anderson, H. C. Matrix vesicles and calcification. Curr. Rheumatol. Rep. 5, 222-226 (2003).
11. Nahar, N. N., Missana, L. R., Garimella, R., Tague, S. E. & Anderson, H. C. Matrix vesicles are carriers of bone morphogenetic proteins (BMPs), vascular endothelial growth factor (VEGF), and noncollagenous matrix proteins. J. Bone Miner. Metab. 26, 514-519 (2008).
12. Fourcade, O. et al. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell 80, 919-927 (1995).
13. Buzas, E. I., Gyorgy, B., Nagy, G., Falus, A. & Gay, S. Emerging role of extracellular vesicles in inflammatory diseases. Nat. Rev. Rheumatol. 10, 356-364 (2014).
14. Goldring, M. B. & Marcu, K. B. Cartilage homeostasis in health and rheumatic diseases. Arthritis Res. Ther. 11, 224 (2009).
15. Berckmans, R. J. et al. Synovial microparticles from arthritic patients modulate chemokine and cytokine release by synoviocytes. Arthritis Res. Ther. 7, R536-R544 (2005).
16. Messer, L. et al. Microparticle-induced release of B lymphocyte regulators by rheumatoid synoviocytes. Arthritis Res. Ther. 11, R40 (2009).
17. Reich, N. et al. Microparticles stimulate angiogenesis by inducing ELR+ CXC-chemokines in synovial fibroblasts. J. Cell. Mol. Med. 15, 756-762 (2011).
18. Kato, T. et al. Exosomes from IL 1β stimulated synovial fibroblasts induce osteoarthritic changes in articular chondrocytes. Arthritis Res. Ther. 16, R163 (2014).
19. Jungel, A. et al. Microparticles stimulate the synthesis of prostaglandin E2 via induction of cyclooxygenase 2 and microsomal prostaglandin E synthase 1. Arthritis Rheum. 56, 3564-3574 (2007).
20. Distler, J. H. et al. The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles. Proc. Natl Acad. Sci. USA 102, 2892-2897 (2005).
21. Gyorgy, B. et al. Improved flow cytometric assessment reveals distinct microvesicle (cell-derived microparticle) signatures in joint diseases. PLoS ONE 7, e49726 (2012).
22. Zhang, H. et al. A membrane form of TNF α presented by exosomes delays T cell activation-induced cell death. J. Immunol. 176, 7385-7393 (2006).
23. Boilard, E. et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 327, 580-583 (2010).
24. Duchez, A. C. et al. Platelet microparticles are internalized in neutrophils via the concerted activity of 12 lipoxygenase and secreted phospholipase A2 IIA. Proc. Natl Acad. Sci. USA 112, E3564-E3573 (2015).
25. Cloutier, N. et al. The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components: the microparticle-associated immune complexes. EMBO Mol. Med. 5, 235-249 (2013).
26. Skriner, K., Adolph, K., Jungblut, P. R. & Burmester, G. R. Association of citrullinated proteins with synovial exosomes. Arthritis Rheum. 54, 3809-3814 (2006).
27. Mor-Vaknin, N. et al. The DEK nuclear autoantigen is a secreted chemotactic factor. Mol. Cell. Biol. 26, 9484-9496 (2006).
28. Sillat, T. et al. Toll-like receptors in human chondrocytes and osteoarthritic cartilage. Acta Orthop. 84, 585-592 (2013).
29. Hu, F. et al. Toll-like receptors expressed by synovial fibroblasts perpetuate Th1 and Th17 cell responses in rheumatoid arthritis. PLoS ONE 9, e100266 (2014).
30. Gomez, R., Villalvilla, A., Largo, R., Gualillo, O. & Herrero-Beaumont, G. TLR4 signalling in osteoarthritis - finding targets for candidate DMOADs. Nat. Rev. Rheumatol. 11, 159-170 (2015).
31. Bretz, N. P. et al. Body fluid exosomes promote secretion of inflammatory cytokines in monocytic cells via Toll-like receptor signaling. J. Biol. Chem. 288, 36691-36702 (2013).
32. Kim, H. A. et al. The catabolic pathway mediated by Toll-like receptors in human osteoarthritic chondrocytes. Arthritis Rheum. 54, 2152-2163 (2006).
33. Liu-Bryan, R. & Terkeltaub, R. Chondrocyte innate immune myeloid differentiation factor 88 dependent signaling drives procatabolic effects of the endogenous Toll-like receptor 2/Toll-like receptor 4 ligands low molecular weight hyaluronan and high mobility group box chromosomal protein 1 in mice. Arthritis Rheum. 62, 2004-2012 (2010).
34. Lo Cicero, A., Majkowska, I., Nagase, H., Di Liegro, I. & Troeberg, L. Microvesicles shed by oligodendroglioma cells and rheumatoid synovial fibroblasts contain aggrecanase activity. Matrix Biol. 31, 229-233 (2012).
35. Pasztoi, M. et al. The recently identified hexosaminidase D enzyme substantially contributes to the elevated hexosaminidase activity in rheumatoid arthritis. Immunol. Lett. 149, 71-76 (2013).
36. Pasztoi, M. et al. Gene expression and activity of cartilage degrading glycosidases in human rheumatoid arthritis and osteoarthritis synovial fibroblasts. Arthritis Res. Ther. 11, R68 (2009).
37. Mu, W., Rana, S. & Zoller, M. Host matrix modulation by tumor exosomes promotes motility and invasiveness. Neoplasia 15, 875-887 (2013).
38. Smith, M. M. & Ghosh, P. The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extracellular environment. Rheumatol. Int. 7, 113-122 (1987).
39. Bellingham, S. A., Coleman, B. M. & Hill, A. F. Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells. Nucleic Acids Res. 40, 10937-10949 (2012).
40. Cheng, L., Sun, X., Scicluna, B. J., Coleman, B. M. & Hill, A. F. Characterization and deep sequencing analysis of exosomal and non-exosomal miRNA in human urine. Kidney Int. 86, 433-444 (2014).
41. Gernapudi, R. et al. Targeting exosomes from preadipocytes inhibits preadipocyte to cancer stem cell signaling in early-stage breast cancer. Breast Cancer Res. Treat. 150, 685-695 (2015).
42. Hong, E. & Reddi, A. H. MicroRNAs in chondrogenesis, articular cartilage, and osteoarthritis: implications for tissue engineering. Tissue Eng. Part B. Rev. 18, 445-453 (2012).
43. Miyaki, S. et al. MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Arthritis Rheum. 60, 2723-2730 (2009).
44. Yamasaki, K. et al. Expression of microRNA 146a in osteoarthritis cartilage. Arthritis Rheum. 60, 1035-1041 (2009).
45. Nakasa, T., Shibuya, H., Nagata, Y., Niimoto, T. & Ochi, M. The inhibitory effect of microRNA 146a expression on bone destruction in collagen-induced arthritis. Arthritis Rheum. 63, 1582-1590 (2011).
46. Boukouris, S. & Mathivanan, S. Exosomes in bodily fluids are a highly stable resource of disease biomarkers. Proteomics Clin. Appl. 9, 358-367 (2015).
47. Cheng, L., Sharples, R. A., Scicluna, B. J. & Hill, A. F. Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood. J. Extracell. Vesicles 3, 23743 (2014).
48. Julich, H., Willms, A., Lukacs-Kornek, V. & Kornek, M. Extracellular vesicle profiling and their use as potential disease specific biomarker. Front. Immunol. 5, 413 (2014).
49. Skog, J. et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 10, 1470-1476 (2008).
50. Vanniasinghe, A. S. et al. Targeting fibroblast-like synovial cells at sites of inflammation with peptide targeted liposomes results in inhibition of experimental arthritis. Clin. Immunol. 151, 43-54 (2014).
51. Metselaar, J. M. et al. Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis. Ann. Rheum. Dis. 63, 348-353 (2004).
52. Kim, S. H. et al. Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis. J. Immunol. 174, 6440-6448 (2005).
53. Heldring, N., Mager, I., Wood, M. J., Le Blanc, K. & Andaloussi, S. E. Therapeutic potential of multipotent mesenchymal stromal cells and their extracellular vesicles. Hum. Gene Ther. 26, 506-517 (2015).
54. Kordelas, L. et al. MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia 28, 970-973 (2014).
55. MacDonald, G. I., Augello, A. & De Bari, C. Role of mesenchymal stem cells in reestablishing immunologic tolerance in autoimmune rheumatic diseases. Arthritis Rheum. 63, 2547-2557 (2011).
56. Robbins, P. D. & Morelli, A. E. Regulation of immune responses by extracellular vesicles. Nat. Rev. Immunol. 14, 195-208 (2014).
57. De Jong, O. G., Van Balkom, B. W., Schiffelers, R. M., Bouten, C. V. & Verhaar, M. C. Extracellular vesicles: potential roles in regenerative medicine. Front. Immunol. 5, 608 (2014).
58. Grande, D. A., Schwartz, J. A., Brandel, E., Chahine, N. O. & Sgaglione, N. Articular cartilage repair: where we have been, where we are now, and where we are headed. Cartilage 4, 281-285 (2013).
59. Savkovic, V. et al. Mesenchymal stem cells in cartilage regeneration. Curr. Stem Cell. Res. Ther. 9, 469-488 (2014).
60. De Windt, T. S. et al. Concise review: unraveling stem cell cocultures in regenerative medicine: which cell interactions steer cartilage regeneration and how? Stem Cells Transl. Med. 3, 723-733 (2014).
61. US National Library of Medicine. ClinicalTrials.gov [online], https://clinicaltrials.gov/ct2/show/NCT02037204 (2014).
62. Caplan, A. I. & Correa, D. The MSC: an injury drugstore. Cell Stem Cell 9, 11-15 (2011).
63. Camussi, G., Deregibus, M. C., Bruno, S., Cantaluppi, V. & Biancone, L. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int. 78, 838-848 (2010).
64. Bruno, S. et al. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J. Am. Soc. Nephrol. 20, 1053-1067 (2009).
65. Baglio, S. R., Pegtel, D. M. & Baldini, N. Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy. Front. Physiol. 3, 359 (2012).
66. Lamichhane, T. N. et al. Emerging roles for extracellular vesicles in tissue engineering and regenerative medicine. Tissue Eng. Part B. Rev. 21, 45-54 (2015).
67. Vonk, L. A., Kragten, A. H., Dhert, W. J., Saris, D. B. & Creemers, L. B. Overexpression of hsa-miR 148a promotes cartilage production and inhibits cartilage degradation by osteoarthritic chondrocytes. Osteoarthr. Cartil. 22, 145-153 (2014).
68. Record, M., Carayon, K., Poirot, M. & Silvente-Poirot, S. Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies. Biochim. Biophys. Acta 1841, 108-120 (2014).
69. Cloutier, N. et al. Platelets can enhance vascular permeability. Blood 120, 1334-1343 (2012).
70. Smith, B. D. & Grande, D. A. The current state of scaffolds for musculoskeletal regenerative applications. Nat. Rev. Rheumatol. 11, 213-222 (2015).
71. Samad, A., Sultana, Y. & Aqil, M. Liposomal drug delivery systems: an update review. Curr. Drug Deliv. 4, 297-305 (2007).
72. Sawada, S. et al. Functional polymer gel-exosomes hybrids for drug delivery system and tissue engineering. [abstract P4C-192], Presented at the 2014 ISEV Annual Meeting (2014).
73. Malda, J. et al. 25th anniversary article: engineering hydrogels for biofabrication. Adv. Mater. 25, 5011-5028 (2013).
74. Visser, J. et al. Biofabrication of multi-material anatomically shaped tissue constructs. Biofabrication 5, 035007 (2013).
75. Dai, S. et al. Phase I clinical trial of autologous ascites-derived exosomes combined with GM CSF for colorectal cancer. Mol. Ther. 16, 782-790 (2008).
76. Wiklander, O. P. et al. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J. Extracell. Vesicles 4, 26316 (2015).
77. Ohno, S. et al. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol. Ther. 21, 185-191 (2013).
78. Hurtig, M. B. et al. Preclinical studies for cartilage repair: recommendations from the International Cartilage Repair Society. Cartilage 2, 137-152 (2011).
79. Bergknut, N. et al. The dog as an animal model for intervertebral disc degeneration? Spine (Phila. Pa 1976) 37, 351-358 (2012).
80. Malda, J. et al. Comparative study of depth-dependent characteristics of equine and human osteochondral tissue from the medial and lateral femoral condyles. Osteoarthr. Cartil. 20, 1147-1151 (2012).
81. Lotvall, J. et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J. Extracell. Vesicles 3, 26913 (2014).
82. Gyorgy, B. et al. Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters. Blood 117, e39-e48 (2011).